Tenet Healthcare Corporation (THC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Tenet Healthcare Corporat...

NYSE: THC · Real-Time Price · USD
202.96
-0.42 (-0.21%)
At close: Oct 03, 2025, 3:59 PM
203.01
0.02%
After-hours: Oct 03, 2025, 05:38 PM EDT

Tenet Healthcare Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
20.69B 20.52B 20.66B 20.97B 20.92B 20.89B 20.55B 20.16B 19.89B 19.45B 19.17B 19.04B 19.13B 19.45B 19.48B 19.54B 19.21B 17.9B
Cost of Revenue
10.09B 12.23B 12.46B 12.68B 12.74B 12.84B 12.74B 12.66B 12.55B 12.31B 12.13B 11.99B 11.98B 12.18B 12.21B 12.24B 12.13B 11.46B
Gross Profit
10.6B 8.29B 8.21B 8.29B 8.17B 8.05B 7.8B 7.5B 7.35B 7.14B 7.05B 7.05B 7.16B 7.27B 7.27B 7.31B 7.08B 6.44B
Operating Income
3.68B 3.61B 5.96B 5.87B 5.35B 5.19B 2.51B 2.31B 2.34B 2.29B 2.33B 2.55B 2.97B 3B 2.87B 3.04B 2.3B 2.18B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
2.98B 2.93B 5.25B 5.11B 4.54B 4.32B 1.62B 1.42B 1.45B 1.35B 1.34B 1.55B 1.95B 2B 1.89B 2.04B 958M 853M
Net Income
1.48B 1.46B 3.2B 3.13B 2.75B 2.62B 611M 469M 499M 414M 411M 558M 876M 957M 914M 1.08B 434M 403M
Selling & General & Admin
2.78B 725M 732M 733M 730M 728M 724M 718M 718M 714M 715M 422M 417M 420M 427M 447M 447M 435M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
4.14B 3.95B 1.52B 1.69B 2.09B 2.13B 4.57B 4.47B 4.29B 4.14B 4B 4.08B 3.77B 3.85B 3.97B 3.82B 4.34B 3.82B
Operating Expenses
6.92B 4.67B 2.25B 2.42B 2.82B 2.86B 5.29B 5.18B 5.01B 4.85B 4.71B 4.5B 4.19B 4.27B 4.4B 4.27B 4.78B 4.26B
Interest Expense
815M 812M 826M 850M 875M 898M 901M 893M 888M 884M 890M 892M 897M 910M 923M 944M 980M 1B
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.01B 16.91B 14.71B 15.1B 15.57B 15.7B 18.04B 17.85B 17.55B 17.16B 16.84B 16.49B 16.17B 16.45B 16.61B 16.5B 16.91B 15.72B
Income Tax Expense
587M 577M 1.18B 1.16B 1B 972M 306M 290M 323M 329M 344M 405M 490M 465M 411M 433M 39M 23M
Shares Outstanding (Basic)
91.14M 94.24M 95.1M 95.67M 97.27M 99.58M 100.96M 101.54M 101.77M 102.29M 104.52M 107.92M 107.79M 107.48M 107.15M 107.05M 106.82M 106.31M
Shares Outstanding (Diluted)
91.79M 95.02M 95.88M 96.65M 98.44M 100.6M 104.17M 104.42M 104.78M 106.01M 106.37M 109.89M 108.75M 112.02M 108.89M 108.76M 108.57M 108.06M
EPS (Basic)
15.74 15.24 32.53 31.61 27.67 26.22 6.02 4.58 4.80 3.94 3.84 5.18 8.16 8.92 8.53 10.13 4.08 3.81
EPS (Diluted)
15.62 15.12 32.23 31.21 27.26 25.77 5.71 4.33 4.55 3.75 3.71 5.08 8.05 8.80 8.42 9.99 4.00 3.73
EBITDA
4.62B 4.56B 6.89B 6.8B 6.27B 6.08B 3.39B 3.18B 3.19B 3.08B 3.08B 3.27B 3.67B 3.74B 3.67B 3.87B 2.83B 2.73B
EBIT
3.8B 3.74B 6.07B 5.96B 5.41B 5.22B 2.52B 2.31B 2.34B 2.23B 2.23B 2.44B 2.84B 2.91B 2.81B 2.98B 1.94B 1.85B
Depreciation & Amortization
816M 816M 818M 841M 856M 861M 870M 867M 852M 855M 841M 829M 829M 834M 855M 887M 893M 878M